COMMUNIQUÉS West-GlobeNewswire

Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune Diseases
04/06/2025
Advances Cullinan’s leadership in T cell engager (TCE) development for autoimmune diseases with both a CD19 TCE and BCMA TCE in its pipeline Strengthens Cullinan portfolio of autoimmune programs with the opportunity to [...]
NurExone Strengthens Path to Clinical Trials for ExoPTEN with New Manufacturing Process Validation
04/06/2025
Company Is also Seeking Shareholder Approval of Amended and Restated Omnibus Plan TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” [...]
RAPT Therapeutics to Participate in Upcoming Investor Conferences
04/06/2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing [...]
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
04/06/2025
GERMANTOWN, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
04/06/2025
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
04/06/2025
BRISBANE, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
04/06/2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]
Finish Healing First: Ekol Hospitals Urges Medical Travellers to Stay Until Fully Cleared
04/06/2025
Photo: Ekol Hospitals via FL Communications IZMIR, Türkiye, June 04, 2025 (GLOBE NEWSWIRE) -- As health-travel numbers continue to climb, people are crossing borders for faster appointments, personalised treatment, and [...]
Multiview Financial Software receives HFMA Peer Review designation
04/06/2025
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed Multiview’s ERP solution using the Peer Review process. After undergoing the rigorous review, Multiview [...]
ALK participates at Jefferies Global Healthcare Conference 2025 in New York
04/06/2025
ALK ( ALKB:DC / OMX: ALK B ) today announced that the company is participating at the Jefferies Global Healthcare Conference 2025 in New York City taking place from 3 - 5 June 2025. Claus Steensen Sølje, Executive Vice [...]
Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision
04/06/2025
TORONTO, June 04, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB), a fast-growing leader in smart logistics technologies, is thrilled to announce the acquisition of a 60% controlling interest in Better Pets, a [...]
Severe Allergic Reactions post Vaccination Discussed in Journal of American Physicians and Surgeons
04/06/2025
TUCSON, Ariz., June 04, 2025 (GLOBE NEWSWIRE) -- Severe allergic reactions involving a cytokine storm can follow vaccination for respiratory viruses such as influenza or COVID-19, writes Irene Mavrakakis , M.D., in the [...]
DirectMeds Acquires Autumn DNA, Expanding into Precision-Based Personalized Wellness
04/06/2025
First-of-its-kind integration introduces DNA-based supplement planning to telehealth—positioning DirectMeds as the leader in data-driven, outcome-focused virtual care SALT LAKE CITY, June 04, 2025 (GLOBE NEWSWIRE) -- [...]
Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares
04/06/2025
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA , AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEELAND, RUSSIA, SWITZERLAND, [...]
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des activités API Solutions et CDMO
04/06/2025
Communiqué de presse Paris – Le 4 juin 2025 - EUROAPI, un leader européen de la production de principes actifs pharmaceutiques (API) et les services de contract development and manufacturing organization (CDMO), annonce [...]
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities
04/06/2025
Press Release Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the [...]
LifeLabs Introduces Three Blood-Based Alzheimer’s Disease Tests, Including Support Services
04/06/2025
Toronto, Ontario, June 04, 2025 (GLOBE NEWSWIRE) -- LifeLabs, a leading provider of health diagnostics and laboratory services, is proud to announce the launch of a comprehensive portfolio of blood-based biomarker tests [...]
Renouvellement du tirage de la ligne Revolving Credit Facility pour une période de six mois
04/06/2025
Communiqué de presse Renouvellement du tirage de la ligne Revolving Credit Facility pour une période de six mois Paris, 4 juin 2025 – Clariane (CLARI.PA – ISIN FR0010386334) annonce avoir renouvelé le 4 juin 2025 le [...]
Renewal of the drawdown under the Revolving Credit Facility for a six-month period
04/06/2025
Press release 4 June 2025 Renewal of the drawdown under the Revolving Credit Facility for a six-month period Paris, 4 June 2025 - Clariane (CLARI.PA - ISIN FR0010386334) announces that it has renewed the drawdown of its [...]

Pages